ZA937714B - Novel formulation - Google Patents

Novel formulation

Info

Publication number
ZA937714B
ZA937714B ZA937714A ZA937714A ZA937714B ZA 937714 B ZA937714 B ZA 937714B ZA 937714 A ZA937714 A ZA 937714A ZA 937714 A ZA937714 A ZA 937714A ZA 937714 B ZA937714 B ZA 937714B
Authority
ZA
South Africa
Prior art keywords
novel formulation
formulation
novel
Prior art date
Application number
ZA937714A
Other languages
English (en)
Inventor
Mary Sou
Craig William Davis
Alison Green Floyd
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA937714B publication Critical patent/ZA937714B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Packages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA937714A 1992-10-19 1993-10-18 Novel formulation ZA937714B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221883A GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation

Publications (1)

Publication Number Publication Date
ZA937714B true ZA937714B (en) 1995-04-18

Family

ID=10723654

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937714A ZA937714B (en) 1992-10-19 1993-10-18 Novel formulation

Country Status (19)

Country Link
EP (1) EP0671919A1 (xx)
JP (1) JPH08502284A (xx)
KR (1) KR950703345A (xx)
AU (1) AU674895B2 (xx)
BR (1) BR9307268A (xx)
CA (1) CA2147889A1 (xx)
CZ (1) CZ63395A3 (xx)
GB (1) GB9221883D0 (xx)
HU (1) HUT75701A (xx)
IL (1) IL107313A0 (xx)
MX (1) MX9306467A (xx)
NO (1) NO951462L (xx)
NZ (1) NZ256890A (xx)
PL (1) PL308459A1 (xx)
SI (1) SI9300545A (xx)
SK (1) SK44795A3 (xx)
TW (1) TW276183B (xx)
WO (1) WO1994008596A1 (xx)
ZA (1) ZA937714B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2185162A4 (en) * 2007-08-10 2012-04-25 Synthrx Inc POLYMER THERAPY FOR THE TREATMENT OF CHRONIC MICROVASCULAR DISEASES
CA2927361A1 (en) 2013-10-16 2015-04-23 Mast Therapeutics, Inc. Diuretic induced alterations of plasma volume
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
EP3747448A1 (en) 2014-07-07 2020-12-09 LifeRaft Biosciences, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
CN109432511A (zh) * 2018-12-29 2019-03-08 常州乐奥医疗科技股份有限公司 一种温敏型水凝胶及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia

Also Published As

Publication number Publication date
IL107313A0 (en) 1994-01-25
TW276183B (xx) 1996-05-21
SK44795A3 (en) 1996-05-08
KR950703345A (ko) 1995-09-20
CA2147889A1 (en) 1994-04-28
CZ63395A3 (en) 1995-07-12
HUT75701A (en) 1997-05-28
NZ256890A (en) 1995-10-26
WO1994008596A1 (en) 1994-04-28
EP0671919A1 (en) 1995-09-20
PL308459A1 (en) 1995-07-24
MX9306467A (es) 1994-05-31
NO951462L (no) 1995-06-13
HU9501104D0 (en) 1995-06-28
GB9221883D0 (en) 1992-12-02
AU5284293A (en) 1994-05-09
JPH08502284A (ja) 1996-03-12
NO951462D0 (no) 1995-04-18
BR9307268A (pt) 1999-05-11
SI9300545A (en) 1994-06-30
AU674895B2 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
GB9325644D0 (en) Novel formulation
GB2268499B (en) Chipping-resistant composition
GB9103824D0 (en) Formulation
GB9214390D0 (en) Formulations
HUT68891A (en) Novel amidoalkyl- and imidoalkyl-piperazines
ZA937714B (en) Novel formulation
GB9207400D0 (en) Novel use
HRP930179A2 (en) Novel antioksidants
LTIP348A (en) Novel sulfonylcarbamides
GB9212757D0 (en) Novel formulation
GB9216361D0 (en) Novel formulation
GB9212711D0 (en) Novel formulation
GB9108128D0 (en) Novel formulation
GB9225583D0 (en) Formulation
ZA928061B (en) Lipomimetic formulation
GB9217322D0 (en) Formulation
GB9205183D0 (en) Formulation
GB9202110D0 (en) Formulation
GB9201915D0 (en) Formulation
ZA93795B (en) Novel triazolopyrimidinesulfonamides
GB9312354D0 (en) Novel formulation
GB9316326D0 (en) Novel formulation
GB9312355D0 (en) Novel formulation
GB9126687D0 (en) Novel formulation
GB9224539D0 (en) Formulations